Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications Industry Satellite Symposium

Concluding remarks (ID 289)

Lecture Time
19:43 - 19:45
Speakers
  • Martin Reck, Grosshansdorf, DE
Session Name
Takeda - Novel therapies for EGFR exon 20 insertions and ALK-positive NSCLC: Developments and implications
Location
South Hall 2, Prague Congress Centre, Prag, Czech Republic
Date
Wed, 30.03.2022
Time
18:15 - 19:45